Nitroglycerin and Inflammatory marker increased - a phase IV clinical study of FDA data

Summary:

Inflammatory marker increased is reported as a side effect among people who take Nitroglycerin (nitroglycerin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tacrolimus, and have Lower respiratory tract infection.

The phase IV clinical study analyzes which people have Inflammatory marker increased when taking Nitroglycerin. It is created by eHealthMe based on reports of 52,631 people who have side effects when taking Nitroglycerin from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Inflammatory marker increased?

Inflammatory marker increased is found to be associated with 396 drugs and 392 conditions by eHealthMe. Check the latest studies of Inflammatory marker increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

52,631 people reported to have side effects when taking Nitroglycerin.
Among them, 60 people (0.11%) have Inflammatory marker increased.

Could Nitroglycerin cause Inflammatory marker increased?

Among these 60 people:

How long have people been on Nitroglycerin when they have Inflammatory marker increased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Inflammatory marker increased when taking Nitroglycerin? *

  • female: 1.75 %
  • male: 98.25 %

What is the age of people who have Inflammatory marker increased when taking Nitroglycerin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Nitroglycerin? *

  1. Eplerenone: 57 people, 95.00%
  2. Prednisolone: 57 people, 95.00%
  3. Furosemide: 57 people, 95.00%
  4. Gliclazide: 57 people, 95.00%
  5. Glucagon: 57 people, 95.00%
  6. Omeprazole: 57 people, 95.00%
  7. Albuterol: 57 people, 95.00%
  8. Tacrolimus: 57 people, 95.00%
  9. Clarithromycin: 56 people, 93.33%
  10. Doxycycline: 56 people, 93.33%

What are other side effects people have besides Inflammatory marker increased? *

  1. Fever: 59 people, 98.33%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 57 people, 95.00%
  3. Lung Consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces): 57 people, 95.00%
  4. Coughing Up Blood: 57 people, 95.00%
  5. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 57 people, 95.00%
  6. Oesophageal Carcinoma (cancer tumour of oesophagus): 57 people, 95.00%
  7. Pneumonia: 57 people, 95.00%
  8. Rales (an abnormal respiratory sound characterized by fine crackles): 57 people, 95.00%
  9. Cardiac Failure Congestive: 57 people, 95.00%
  10. Pleural Effusion (water on the lungs): 57 people, 95.00%

What are the existing conditions these people have? *

  1. Lower Respiratory Tract Infection: 47 people, 78.33%
  2. Gastric Ulcer (stomach ulcer): 46 people, 76.67%
  3. Pneumonia: 43 people, 71.67%
  4. Mediastinitis (inflammation of the tissues in the mid-chest): 36 people, 60.00%
  5. Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 2 people, 3.33%
  6. Rashes (redness): 2 people, 3.33%
  7. Indigestion: 2 people, 3.33%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 3.33%
  9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and have Inflammatory marker increased?

- Check whether Inflammatory marker increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitroglycerin:

Inflammatory marker increased treatments and more:

How severe was Inflammatory marker increased and when was it recovered:

Expand to all the drugs that have ingredients of nitroglycerin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammatory marker increased:

Browse all the conditions that are associated with Inflammatory marker increased:


How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitroglycerin) and Nitroglycerin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: